References
- Adami HO, Chow WH, Nyren O, et al (1996). Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst, 88, 1472-7. https://doi.org/10.1093/jnci/88.20.1472
- Aekplakorn W, Stolk RP, Neal B, et al (2003). The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care, 26, 2758-63. https://doi.org/10.2337/diacare.26.10.2758
- Browning JD, Szczepaniak LS, Dobbins R, et al (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol, 40, 1387-95. https://doi.org/10.1002/hep.20466
- Cheung O, Sanyal AJ (2008). Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis, 12, 573-85. https://doi.org/10.1016/j.cld.2008.03.005
- Deerochanawong C, Ferrario A (2013). Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health, 9, 11. https://doi.org/10.1186/1744-8603-9-11
- Eguchi Y, Hyogo H, Ono M, et al (2012). Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol, 47, 586-95. https://doi.org/10.1007/s00535-012-0533-z
- Fan JG (2007). [An introduction of strategies for the management of nonalcoholic fatty liver disease (NAFLD) recommended by Asia Pacific Working Party on NAFLD]. Zhonghua Gan Zang Bing Za Zhi, 15, 552-3.
- Fan JG, Zhu J, Li XJ, et al (2005). Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol, 43, 508-14. https://doi.org/10.1016/j.jhep.2005.02.042
- Foster T, Anania FA, Li D, et al (2013). The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig Dis Sci, 58, 2392-8. https://doi.org/10.1007/s10620-013-2652-7
- Fung J, Lee CK, Chan M, et al (2014). High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census. Liver Int. (in press).
- Hsing AW, Zhang M, Rashid A, et al (2008). Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer, 122, 1849-53.
- Hu X, Huang Y, Bao Z, et al (2012). Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol, 12, 123. https://doi.org/10.1186/1471-230X-12-123
- Jeong EH, Jun DW, Cho YK, et al (2013). Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin Mol Hepatol, 19, 266-72. https://doi.org/10.3350/cmh.2013.19.3.266
- Jing W, Jin G, Zhou X, et al (2012). Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev, 21, 24-31. https://doi.org/10.1097/CEJ.0b013e3283481d89
- Kim SH, Lee JW, Hwang HJ (2011). Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults. Asia Pac J Clin Nutr, 20, 14-20.
- Leite NC, Salles GF, Araujo AL, et al (2009). Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int, 29, 113-9. https://doi.org/10.1111/j.1478-3231.2008.01718.x
- Loomba R, Sanyal AJ (2013). The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol, 10, 686-90. https://doi.org/10.1038/nrgastro.2013.171
- Mohammad-Alizadeh AH, Ghobakhlou M, Shalmani HM, et al (2012). Cholangiocarcinoma: an-eight-year experience in a tertiary-center in Iran. Asian Pac J Cancer Prev, 13, 5381-4. https://doi.org/10.7314/APJCP.2012.13.11.5381
- O'Shea RS, Dasarathy S, McCullough AJ, et al (2010). Alcoholic liver disease. Hepatol, 51, 307-28. https://doi.org/10.1002/hep.23258
- Palmer WC, Patel T (2012). Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol, 57, 69-76. https://doi.org/10.1016/j.jhep.2012.02.022
- Shaib YH, El-Serag HB, Davila JA, et al (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterol, 128, 620-6. https://doi.org/10.1053/j.gastro.2004.12.048
- Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 87, 4-14. https://doi.org/10.1016/j.diabres.2009.10.007
- Shebl FM, Andreotti G, Meyer TE, et al (2011). Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer, 105, 1424-9. https://doi.org/10.1038/bjc.2011.363
- Shi L, Liu ZW, Li Y, et al (2012). The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci, 25, 383-91.
- Silva IdS (1999). Cancer Epidemiology: Principles and Methods. IARC Press.
- StataCorp LP (2007). Stata Release 10: User's guide. College Station TX: Stata Press.
- Suomela E, Oikonen M, Virtanen J, et al (2014). Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Ann Med, 1-7.
- Welzel TM, Graubard BI, El-Serag HB, et al (2007a). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8. https://doi.org/10.1016/j.cgh.2007.05.020
- Welzel TM, Mellemkjaer L, Gloria G, et al (2007b). Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study. Int J Cancer, 120, 638-41. https://doi.org/10.1002/ijc.22283
- Wong VW, Wong GL, Chu WC, et al (2012). Hepatitis B virus infection and fatty liver in the general population. J Hepatol, 56, 533-40. https://doi.org/10.1016/j.jhep.2011.09.013
- Wu Y, Ahmed A, Kamal A (2013). Donor diabetes mellitus is an independent risk factor for graft loss in HCV positive but not HCV negative liver transplant recipients. Dig Dis Sci, 58, 574-8. https://doi.org/10.1007/s10620-012-2345-7
- Xiao SJ, Fu GJ, Lv YL, et al (2014). Prevalence and risk factors of fatty liver disease in young and middle-aged population: one center study in Southwestern China. J Gastroenterol Hepatol, 29, 358-64. https://doi.org/10.1111/jgh.12334
- Yan Y, Bian H, Xia MF, et al (2013). Liver disease spectrum in hospitalized type 2 diabetes and related risk factors analysis of non-alcoholic fatty liver disease. Zhonghua Yi Xue Za Zhi, 93, 270-4 (in Chinese).
Cited by
- Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling vol.15, pp.1, 2017, https://doi.org/10.1186/s12967-017-1342-1
- Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score) vol.37, pp.10, 2017, https://doi.org/10.1111/liv.13413
- A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand vol.10, pp.1, 2016, https://doi.org/10.1371/journal.pntd.0004293
- Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes vol.42, pp.8, 2018, https://doi.org/10.1007/s00268-017-4453-1
- Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival vol.288, pp.1, 2018, https://doi.org/10.1148/radiol.2018171593